NLM Logo

CAV protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
CAV protocol
Unique ID
C034482
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C034482
Entry Term(s)
ACO II protocol
AVC protocol
CADO protocol
DVC protocol
NCI PB 93-C-125 protocol
NHL-15 protocol
VAC regimen
VDC regimen
Registry Number
0
Previous Indexing
*CYCLOPHOSPHAMIDE (82-83)
*DOXORUBICIN (82-83)
*VINCRISTINE (82-83)
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Doxorubicin
Vincristine
Frequency
310
Note
chemotherapy protocol consisting of cyclophosphamide, adriamycin, vincristine; CAV refers to first source; acronym ACV refers to second source; acronym ACO II was used in Klin Wochenschr 1982;60(16):829; acronym ACO was used in Onkology 1982;5(4):174; acronym DVC was used in Gan To Kagaku Ryoho 1984;11(4):888
Source
Dtsch Med Wochenschr 1981;106(39):1260
Int J Radiat Oncol Biol Phys 1982;8(2):191
Date of Entry
1982/06/18
Revision Date
2010/07/12
CAV protocol Preferred
AVC protocol Narrower
CADO protocol Narrower
VDC regimen Narrower
NCI PB 93-C-125 protocol Narrower
NHL-15 protocol Narrower
VAC regimen Narrower
ACO II protocol Narrower
DVC protocol Narrower
page delivered in 0.005s